Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism
- 1 July 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 332 (1) , 9-14
- https://doi.org/10.1016/s0014-2999(97)01025-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channelsEuropean Journal of Pharmacology, 1995
- Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipinePsychopharmacology, 1993
- Clinical Features and Management of Intoxication Due to Hallucinogenic DrugsDrug Safety, 1989
- Startle Habituation and Sensorimotor Gating in Schizophrenia and Related Animal ModelsSchizophrenia Bulletin, 1987
- Hallucinations: theoretical and clinical overviewAmerican Journal of Psychiatry, 1986
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agentsLife Sciences, 1984
- Phencyclidine, Lysergic Acid Diethylamide, and Mescaline: Cerebral Artery Spasms and Hallucinogenic ActivityScience, 1981
- Levodopa-induced psychosis: a kindling phenomenonAmerican Journal of Psychiatry, 1978
- Psychoses Precipitated by Psychotomimetic DrugsArchives of General Psychiatry, 1977
- Studies on Lysergic Acid Diethylamide (LSD-25)A.M.A. Archives of Neurology & Psychiatry, 1956